30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

MiMedx Planning U.S. Launch for Ambient Temperature Version of OrthoFlo -

MiMedx is planning a U.S. launch for a next-generation lyophilized (freeze-dried) version of OrthoFlo, its amniotic fluid-based allograft for use in in orthopaedic and sports medicine applications.  

This anticipated version of OrthoFlo can be stored at ambient temperature and has a five-year shelf life. 

Date of product launch was not specified.

Source: MiMedx Group Inc.


This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.